Overview

Maintenance Chemotherapy in Metastatic Breast Cancer

Status:
Unknown status
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, prospective and multicenter phase III study. Two-hundred-sixty-two (262) patients on each arm will be recruited in the study.
Phase:
Phase 3
Details
Lead Sponsor:
MANTA 1 Study Italian Collaborative Group
Collaborator:
Bristol-Myers Squibb
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel